• Aucun résultat trouvé

Kidney International and the COVID-19 infection

N/A
N/A
Protected

Academic year: 2021

Partager "Kidney International and the COVID-19 infection"

Copied!
2
0
0

Texte intégral

(1)

HAL Id: inserm-02555137

https://www.hal.inserm.fr/inserm-02555137

Submitted on 27 Apr 2020

HAL is a multi-disciplinary open access

archive for the deposit and dissemination of

sci-entific research documents, whether they are

pub-lished or not. The documents may come from

teaching and research institutions in France or

abroad, or from public or private research centers.

L’archive ouverte pluridisciplinaire HAL, est

destinée au dépôt et à la diffusion de documents

scientifiques de niveau recherche, publiés ou non,

émanant des établissements d’enseignement et de

recherche français ou étrangers, des laboratoires

publics ou privés.

Kidney International and the COVID-19 infection

Brad Rovin, Pierre Ronco

To cite this version:

Brad Rovin, Pierre Ronco. Kidney International and the COVID-19 infection. Kidney International,

Nature Publishing Group, 2020, 97 (5), pp.823. �10.1016/j.kint.2020.03.010�. �inserm-02555137�

(2)

Kidney International and the COVID-19

infection

OPEN

Kidney International (2020) 97, 823;https://doi.org/10.1016/j.kint.2020.03.010

KEYWORDS: education; microbiology

Copyrightª 2020, International Society of Nephrology. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

T

he Editorial Team of Kidney International would like to reassure our readership that we will continue to bring you high-quality information throughout the COVID-19 pandemic to help all of us deal with the crisis and provide high-quality care to our pa-tients. We have a mechanism in place to rapidly review and arrive at publication decisions for papers on the COVID-19–related implications for the kidney and release these papers in an open access format within one week after acceptance. We believe the best way nephrolo-gists can contribute to thefight against this dis-ease is by arming ourselves with the best and most up-to-date data possible.

The Editors of Kidney International would also like to thank all of our reviewers for their outstanding work in guiding the publication of high-impact papers. We understand that for most of us now many of our academic activities have been curtailed as we focus our efforts on combating the virus. We apologize to our au-thors for any delays encountered in the review process for non–COVID-19–related articles. Normal turnaround time for Kidney Interna-tional averages 14 days for all original manu-scripts, and we will make every effort to

maintain a short review process during this time of stress.

During thefirst quarter of 2020 the number of submitted manuscripts to Kidney Interna-tional has increased by 15%, and we are grateful to the authors for choosing to publish with us despite the pandemic. We are very much aware of the huge professional and personal diffi-culties authors are facing, including the shut-down of laboratories and the virtual standstill of most clinical trials, and we will take these difficulties into account during the review process.

Despite all of these challenges, the Editorial Team remains dedicated to the mission of Kidney International, and we are proud to serve the kidney community and contribute, together with the International Society of Nephrology, to global kidney health. We are happy to hear from our readership and will appreciate any suggestions of how we can help you manage during this crisis.

APPENDIX

List of Associate Editors

P. Toby Coates, Olivier Devuyst, Tilman B. Drueke, Jürgen Floege, Agnes B. Fogo, T. Alp Ikizler, Masaomi Nangaku, Jai Radhakrishnan, Germaine Wong, and Christina Wyatt. Brad H. Rovin1,

Deputy Editor,

Pierre Ronco2,3,4, Editor-in-Chief, and Associate Editors5; for the Entire Editorial Team

1Internal Medicine–Nephrology, The Ohio State University, Columbus, Ohio, USA; 2

Sorbonne Université, Paris, France;3Institut National de la Santé et de la Recherche Médicale (Inserm), Unité Mixte de Recherche S1155, Paris, France; and4Hôpital de jour -Néphrologie, Assistance Publique-Hôpitaux de Paris, Hôpital Tenon, Paris, France Correspondence: Brad H. Rovin, Internal Medicine– Nephrology, The Ohio State University, 395 W. 12th Avenue, Ground Floor, Columbus, Ohio 43210, USA. E-mail:Brad.rovin@ osumc.edu

5See theAppendixfor a list of the Associate Editors.

www.kidney-international.org

e d i t o r i a l

Références

Documents relatifs

Based on the analyses of 33,865 droplets, yielding 27,203 annotated cells after rigorous quality control (Fig. S1A and S2B), we identified immune, endothelial, developing

The main results of this paper show that (1) family firms have higher stock returns than widely held firms and those with another blockholder; (2) considering a number of

More efficient renal urea excretion Insulin Glomerular hyperfiltration Reduced tubular urea reabsorption cAMP release in blood

MESH Keywords Calcineurin ; antagonists & inhibitors ; Cytochrome P-450 CYP3A ; genetics ; Dose-Response Relationship, Drug ; Enzyme Inhibitors ;

Pilot Randomized Controlled Trial of Increased Water Intake in Chronic Kidney Disease It seems plausible, certainly from the basic studies in animals and more recently

Given the differences between the transplant and non-transplant cohorts’ baseline characteristics, we performed a matched analysis after adjusting for known risk factors of

Due to the relatively small number of population-based studies, and inconsistent results in the published literature, we investigated the relationship between asbestos exposure

En eet, si toutes les régulations reposent sur des intera tions molé ulaires (semblables à elles étudiées dans la première partie), la présen e de milliards de molé ules fait